Synbiotic Health is a biotechnology startup founded in 2019 and based in the United States. The company is at the forefront of the microbiome industry, positioning itself as the microbiome experts®. Synbiotic Health differentiates itself through its Leading with Science™ approach, focusing on the development, clinical research, and market introduction of its Ecologically-Advanced™ probiotics aimed at improving health.
The company's unique selling point lies in its innovative discovery platforms IVS™ and IVE™, which are instrumental in pioneering a new category of Synergistic Synbiotics™. These synbiotics are proprietary select combinations of Ecologically Advanced™ probiotics and prebiotics, specifically designed to transform the microbiome for documented health benefits.
At Synbiotic Health, the focus is on understanding the ecological framework in the gut to establish beneficial bacteria and bring about competition with resident microbes. This comprehensive approach takes into consideration the entire ecosystem, emphasizing specific traits and functions necessary for probiotics to not only support human health but also outperform existing offerings in the market.
The company's last investment, a $500.00K Seed Round investment on 17 November 2023, came from Invest Nebraska. Overall, Synbiotic Health stands as a promising player in the biotechnology and food and beverage industries, showcasing its commitment to Better Science for Better Health™.
No recent news or press coverage available for Synbiotic Health.